WuXi AppTec Sells Advanced Therapies Unit to Altaris LLC
WuXi AppTec sells its cell and gene therapy manufacturing unit, WuXi Advanced Therapies, to U.S. firm Altaris LLC, marking a significant move in healthcare M&A.
WuXi AppTec, a Chinese company, announced the sale of its cell and gene therapy manufacturing unit, WuXi Advanced Therapies, to U.S.-based private equity firm Altaris LLC.